Skip Navigation



ToxSci Advance Access published online on June 18, 2009

Toxicological Sciences, doi:10.1093/toxsci/kfp135
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow All Versions of this Article:
111/1/189    most recent
kfp135v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pogrmic, K.
Right arrow Articles by Kovacevic, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pogrmic, K.
Right arrow Articles by Kovacevic, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

Atrazine Oral Exposure of Peripubertal Male Rats Down-Regulates Steroidogenesis Gene Expression in Leydig Cells

K. Pogrmic, S. Fa, V. Dakic, S. Kaisarevic and R. Kovacevic

Laboratory for Ecotoxicology, Department of Biology and Ecology, University of Novi Sad Faculty of Sciences, 21000 Novi Sad, Serbia

Radmila Kovacevic, PhD, LECOTOX, Department of Biology and Ecology, University of Novi Sad, Faculty of Sciences, Trg D. Obradovica 2, 21000 Novi Sad, Serbia, Tel: +381 21 485 2675, Fax: +381 21 450 620, E-mail: radmilak{at}ib.ns.ac.yu

Received April 2, 2009; revision received June 3, 2009; accepted June 15, 2009


   Abstract

In the present study, we investigated the effects of oral dosing of atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine) to peripubertal male rats (50mg/kg and 200mg/kg body weight daily from postnatal day 23 to 50) on ex vivo Leydig cell steroidogenesis. Leydig cells from treated rats were characterised by significant decline in mRNA transcripts of several genes responsible for steroidogenesis: luteinizing hormone receptor (LHR), scavenger receptor-B1, steroidogenic acute regulatory protein, translocator protein, steroidogenic factor-1, phosphodiesterase 4B, 3β–hydroxysteroid dehydrogenase (HSD), CYP17A1 and 17βHSD. In the presence of human chorion gonadotropin, the dose-dependent decrease in extra cellular cAMP level and accordingly strong inhibition of androgenesis were obtained. The transcription of LHR gene in Leydig cells of atrazine-treated rats was down-regulated in a dose-dependent manner, which could be the reason for reduction in cAMP level and expression of cAMP-dependent genes. To clarify the activity of the steroidogenic enzymes responsible for androgenesis, purified Leydig cells were challenged with different steroid substrates (22OH-cholesterol, pregnenolone, progesterone and {Delta}4–androstenedione), and the obtained results indicated inhibition of androgen production in Leydig cells isolated from atrazine-treated animals in the presence of all those substrates. However, when Leydig cells were challenged with 22OH-cholesterol, the progesterone level in the incubation medium was unchanged, indicating that decrease in cholesterol transport and/or CYP17A1 and 17βHSD activity are most probably responsible for inhibition of androgen production after the addition of different substrates. Our results demonstrated that in vivo exposure to atrazine affects Leydig cell steroidogenesis via the inhibition of steroidogenesis gene expression, which is accompanied by decreased androgenesis.

Key Words: atrazine; gene expression; LC steroidogenesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.